Showing results (1-10 of 169) with videos related to
Sort By:
Pageof 17
Psychiatrische Praxis|April 9, 2005
[Extrapyramidal side-effects: avoidance, diagnosis and treatment]W Wolfgang Fleischhacker, Christian WidschwendterArchives of General Psychiatry|December 7, 2005
Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysisGeorg Kemmler, Martina Hummer, Christian Widschwendter, et al.The Journal of Clinical Psychiatry|March 26, 2009
Tolerability of antipsychotics: recent controversies and future managementW Wolfgang FleischhackerEuropean Psychiatry : the Journal of the Association of European Psychiatrists|April 11, 2013
Second-generation antipsychotics: are their similarities greater than their differences?W Wolfgang FleischhackerThe British Journal of Psychiatry. Supplement|November 3, 2009
Second-generation antipsychotic long-acting injections: systematic reviewW Wolfgang FleischhackerSchizophrenia Research|September 6, 2005
Comparative efficacy of antipsychotics in the treatment of schizophrenia: a critical assessmentRajiv Tandon, W Wolfgang FleischhackerPsychopharmacology|July 11, 2002
Feasibility of placebo-controlled clinical trials of antipsychotic compounds in EuropeW Wolfgang Fleischhacker, Tom Burns, Expert Opinion on Emerging Drugs|May 14, 2011
Emerging drugs for schizophreniaFalko Biedermann, W Wolfgang FleischhackerCurrent Opinion in Psychiatry|April 7, 2009
Antipsychotics in the early stage of developmentFalko Biedermann, W Wolfgang FleischhackerPageof 17